Douglas Beck Sells 4,526 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) SVP Douglas Beck sold 4,526 shares of the company’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of $135.81, for a total value of $614,676.06. Following the transaction, the senior vice president directly owned 28,544 shares in the company, valued at approximately $3,876,560.64. The trade was a 13.69% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

Adtalem Global Education stock opened at $127.85 on Thursday. Adtalem Global Education Inc. has a one year low of $86.97 and a one year high of $156.26. The firm’s fifty day simple moving average is $125.00. The stock has a market capitalization of $4.35 billion, a PE ratio of 18.16, a PEG ratio of 0.94 and a beta of 0.62. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.09 and a quick ratio of 1.09.

Adtalem Global Education (NYSE:CVSA) last issued its earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. The business had revenue of $501.38 million during the quarter. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, sell-side analysts expect that Adtalem Global Education Inc. will post 8.99 EPS for the current fiscal year.

Hedge Funds Weigh In On Adtalem Global Education

A hedge fund recently bought a new position in Adtalem Global Education stock. Kendall Capital Management bought a new stake in shares of Adtalem Global Education Inc. (NYSE:CVSA) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages recently issued reports on CVSA. Truist Financial raised their target price on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, May 11th. Weiss Ratings reissued a “hold (c+)” rating on shares of Adtalem Global Education in a report on Friday, May 22nd. Barrington Research restated an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a research note on Monday, June 8th. Finally, Wall Street Zen raised Adtalem Global Education from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $155.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.